Skip to main content
. 2020 Jul 22;20:684. doi: 10.1186/s12885-020-07176-7

Table 2.

Responses among patients with measurable lesions

All (n = 49) Good (n = 27) Poor (n = 22)
CR 0 0 0
PR 3 2 1
SD 8 5 3
PD 36 19 17
NE 2 1 1
RR (%) 6% 8% 5%
DCR (%) 23% 27% 19%

CR complete response, PR partial response, SD stable disease, PD progressive disease, NE not evaluable, RR response rate, DCR disease control rate (CR + PR + SD)